Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
GW627368
Cat. No.:
0225LY-1134
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
GW627368X serves as a highly selective and potent antagonist of the prostanoid EP4 receptor.
Synonym:
GW 627368X; 439288-66-1; GW 627368; GW-627368X; GW627368X; GW-627368; 2-(4-(4,9-Diethoxy-1-oxo-1H-benzo[f]isoindol-2(3H)-yl)phenyl)-N-(phenylsulfonyl)acetamide; N-(benzenesulfonyl)-2-[4-(4,9-diethoxy-3-oxo-1H-benzo[f]isoindol-2-yl)phenyl]acetamide; 2-(4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl)-N-(phenylsulfonyl)acetamide; Benzeneacetamide, 4-(4,9-diethoxy-1,3-dihydro-1-oxo-2H-benz(f)isoindol-2-yl)-N-(phenylsulfonyl)-; 4-(4,9-diethoxy-1,3-dihydro-1-oxo-2H-benz[f]isoindol-2-yl)-N-(phenylsulfonyl)-benzeneacetamide
CAS No.:
439288-66-1
Compound CID:
5312130
Formula:
C30H28N2O6S
Formula Weight:
544.62
Specification
Relative Density:
1.327 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
GW627368 can be used in receptor pharmacology to investigate the selective antagonism of the prostanoid EP4 receptor.
Library Information
Target:
Prostaglandin receptor
Receptor:
PTGER4
Pathways:
GPCR/G protein signaling; Immunology/Inflammation
Plate Number:
AOCL-15
Plate Location:
e10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
50 mg/mL; 91.81 mM
